232 related articles for article (PubMed ID: 35216506)
1. PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells.
Shin WS; Park MK; Kim JH; Oh SW; Jang JY; Lee H; Lee ST
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216506
[TBL] [Abstract][Full Text] [Related]
2. Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma.
Kim JH; Shin WS; Lee SR; Kim S; Choi SY; Lee ST
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293051
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma.
Shin WS; Kwon J; Lee HW; Kang MC; Na HW; Lee ST; Park JH
Cancer Sci; 2013 Aug; 104(8):1120-6. PubMed ID: 23663482
[TBL] [Abstract][Full Text] [Related]
4. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells.
Shin WS; Hong Y; Lee HW; Lee ST
Oncotarget; 2016 Nov; 7(45):73242-73256. PubMed ID: 27689325
[TBL] [Abstract][Full Text] [Related]
5. Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.
Shin WS; Lee HW; Lee ST
FASEB J; 2019 Nov; 33(11):12960-12971. PubMed ID: 31490704
[TBL] [Abstract][Full Text] [Related]
6. Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.
Shin WS; Gim J; Won S; Lee ST
Sci Rep; 2018 Jun; 8(1):8519. PubMed ID: 29867084
[TBL] [Abstract][Full Text] [Related]
7. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.
Liu K; Song G; Zhang X; Li Q; Zhao Y; Zhou Y; Xiong R; Hu X; Tang Z; Feng G
World J Surg Oncol; 2017 May; 15(1):105. PubMed ID: 28545451
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer.
Kim JH; Kwon J; Lee HW; Kang MC; Yoon HJ; Lee ST; Park JH
Oncol Rep; 2014 Jun; 31(6):2708-12. PubMed ID: 24789704
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling.
Shin WS; Oh SW; Park HN; Kim JH; Lee ST
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569547
[TBL] [Abstract][Full Text] [Related]
10. PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.
Park M; Yoon HJ; Kang MC; Kwon J; Lee HW
Tumour Biol; 2016 Oct; 37(10):14217-14224. PubMed ID: 27557627
[TBL] [Abstract][Full Text] [Related]
11. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
12. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
13. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
[TBL] [Abstract][Full Text] [Related]
14. USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1.
Song C; Peng J; Wei Y; Shao J; Chen X; Zhang X; Xu J
Exp Cell Res; 2021 Dec; 409(1):112884. PubMed ID: 34743935
[TBL] [Abstract][Full Text] [Related]
15. HOXD11 upregulates JAM-A and exerts oncogenic properties via NF-κB signaling pathway in esophageal squamous cell carcinoma.
Xiong R; Long Q; Zhang X; Xu J; Liu Y; Xiong L; Yang S; Feng G; Song G; Liu K
Hum Cell; 2023 Jan; 36(1):244-257. PubMed ID: 36214988
[TBL] [Abstract][Full Text] [Related]
16. The role of B3GNT3 as an oncogene in the growth, invasion and migration of esophageal cancer cells.
Lu J; Lei T; Yu H; Su X; Zhang L; Zhang Y
Acta Cir Bras; 2023; 38():e380923. PubMed ID: 36995820
[TBL] [Abstract][Full Text] [Related]
17. RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6.
Li L; Lv L; Xu JC; He Q; Chang N; Cui YY; Tao ZC; Zhu T; Qian LT
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982663
[TBL] [Abstract][Full Text] [Related]
18. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
19. MTA1 promotes tumorigenesis and development of esophageal squamous cell carcinoma via activating the MEK/ERK/p90RSK signaling pathway.
Nan P; Wang T; Li C; Li H; Wang J; Zhang J; Dou N; Zhan Q; Ma F; Wang H; Qian H
Carcinogenesis; 2020 Sep; 41(9):1263-1272. PubMed ID: 31783401
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.
Lhoumeau AC; Martinez S; Boher JM; Monges G; Castellano R; Goubard A; Doremus M; Poizat F; Lelong B; de Chaisemartin C; Bardin F; Viens P; Raoul JL; Prebet T; Aurrand-Lions M; Borg JP; Gonçalves A
PLoS One; 2015; 10(5):e0123768. PubMed ID: 25962058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
